117 related articles for article (PubMed ID: 38182134)
21. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
Lee HS; Lee J; Jo JC; Jung SH; Lee JJ; Kim D; Lee S; Song K
Sci Rep; 2021 Nov; 11(1):22907. PubMed ID: 34824362
[TBL] [Abstract][Full Text] [Related]
22. Association of frailty and chemotherapy-related adverse outcomes in geriatric patients with cancer: a pilot observational study in Taiwan.
Ho YW; Tang WR; Chen SY; Lee SH; Chen JS; Hung YS; Chou WC
Aging (Albany NY); 2021 Nov; 13(21):24192-24204. PubMed ID: 34747717
[TBL] [Abstract][Full Text] [Related]
23. Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study.
Farcet A; de Decker L; Pauly V; Rousseau F; Bergman H; Molines C; Retornaz F
PLoS One; 2016; 11(2):e0149732. PubMed ID: 26918947
[TBL] [Abstract][Full Text] [Related]
24. Impact of sepsis on Eastern Cooperative Oncology Group performance status among fully ambulatory patients: a prospective nationwide multicenter cohort.
Lee KJ; Park JY; Jeon K; Ko RE; Suh GY; Lim SY; Lee YJ; Oh DK; Park MH; Lim CM; Park S
J Thorac Dis; 2023 Sep; 15(9):4681-4692. PubMed ID: 37868852
[TBL] [Abstract][Full Text] [Related]
25. Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
Käsmann L; Taugner J; Eze C; Roengvoraphoj O; Dantes M; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Anticancer Res; 2019 Sep; 39(9):5077-5081. PubMed ID: 31519618
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.
Langer C; Li S; Schiller J; Tester W; Rapoport BL; Johnson DH;
J Clin Oncol; 2007 Feb; 25(4):418-23. PubMed ID: 17264337
[TBL] [Abstract][Full Text] [Related]
27. Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study.
Farmakis IT; Barco S; Mavromanoli AC; Konstantinides SV; Valerio L
JACC CardioOncol; 2022 Nov; 4(4):507-518. PubMed ID: 36444229
[TBL] [Abstract][Full Text] [Related]
28. Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.
Ali R; Gabr A; Abouchaleh N; Al Asadi A; Mora RA; Kulik L; Abecassis M; Riaz A; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):260-269. PubMed ID: 28879621
[TBL] [Abstract][Full Text] [Related]
29. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
[TBL] [Abstract][Full Text] [Related]
30. Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer.
Muchnik E; Loh KP; Strawderman M; Magnuson A; Mohile SG; Estrah V; Maggiore RJ
J Am Geriatr Soc; 2019 May; 67(5):905-912. PubMed ID: 30698276
[TBL] [Abstract][Full Text] [Related]
31. Patient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignancies.
Giri S; Al-Obaidi M; Harmon C; Clark D; Ubersax C; Dai C; Young-Smith C; Outlaw D; Gbolahan O; Khushman M; Bhatia S; Williams GR
J Am Geriatr Soc; 2023 Jan; 71(1):136-144. PubMed ID: 36208421
[TBL] [Abstract][Full Text] [Related]
32. Beyond Performance Status.
Simcock R; Wright J
Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):553-561. PubMed ID: 32684503
[TBL] [Abstract][Full Text] [Related]
33. Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice.
Ksienski D; Wai ES; Croteau N; Freeman AT; Chan A; Fiorino L; Brooks EG; Poonja Z; Fenton D; Geller G; Irons S; Lesperance M
Lung Cancer; 2019 Jul; 133():110-116. PubMed ID: 31200816
[TBL] [Abstract][Full Text] [Related]
34. The association of polypharmacy with functional status impairments, frailty, and health-related quality of life in older adults with gastrointestinal malignancy - Results from the Cancer and Aging Resilience Evaluation (CARE) registry.
Outlaw D; Dai C; Al-Obaidi M; Harmon C; Giri S; Bhatia S; Williams GR
J Geriatr Oncol; 2022 Jun; 13(5):624-628. PubMed ID: 34998720
[TBL] [Abstract][Full Text] [Related]
35. Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older.
Driver JA; Viswanathan AN
Gynecol Oncol; 2017 Jun; 145(3):526-530. PubMed ID: 28359689
[TBL] [Abstract][Full Text] [Related]
36. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
[TBL] [Abstract][Full Text] [Related]
37. Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study.
Dawe DE; Rittberg R; Syed I; Shanahan MK; Moldaver D; Bucher O; Galloway K; Reynolds K; Paul JT; Harlos C; Kim JO; Banerji S
Front Oncol; 2023; 13():1191855. PubMed ID: 37795434
[TBL] [Abstract][Full Text] [Related]
38. Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.
Bergerot CD; Philip EJ; Bergerot PG; Hsu J; Dizman N; Salgia M; Salgia N; Vaishampayan U; Battle D; Loscalzo M; Dale W; Pal SK
Cancer; 2021 Feb; 127(3):354-358. PubMed ID: 33007114
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data.
Wilkinson S; Gupta A; Scheuer N; Mackay E; Arora P; Thorlund K; Wasiak R; Ray J; Ramagopalan S; Subbiah V
JAMA Netw Open; 2021 Oct; 4(10):e2126306. PubMed ID: 34618040
[TBL] [Abstract][Full Text] [Related]
40. Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?
Baldotto CS; Cronemberger EH; de Biasi P; Zamboni M; Sousa A; Zukin M; Small IA; Ferreira CG
Support Care Cancer; 2012 Nov; 20(11):2721-7. PubMed ID: 22322592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
